Dr. Stephanie Dorta-Estremera's lab at the University of Puerto Rico focuses on using non-pathogenic Streptococcus bacteria to develop new treatments for oropharyngeal squamous cell carcinoma (OSCC). By studying how these bacteria can trigger immune responses and affect cancer cell survival, the lab aims to identify affordable and effective therapies that can improve outcomes for patients, particularly within minority communities. Students in the lab gain valuable experience in cancer research, microbiology, and immunology.